|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| A61K 31/4545 | (2013.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 27/02 | (2018.01) |
| (11) | Number of the document | 3763369 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20174399.4 |
| Date of filing the European patent application | 2013-04-02 | |
| (97) | Date of publication of the European application | 2021-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 12162937 | 2012-04-03 | EP |
| (72) |
NIVENS, Michael Chadham , DE
BOUYSSOU, Thierry , DE
GOEGGEL, Rolf , DE
SEITHER, Peter , DE
|
| (73) |
Alkahest, Inc. ,
125 Shoreway Road, Suite D, San Carlos, CA 94070,
US
|
| (54) | USE OF CCR3-INHIBITORS FOR TREATING DRY AGE-RELATED MACULAR DEGENERATION |
| USE OF CCR3-INHIBITORS FOR TREATING DRY AGE-RELATED MACULAR DEGENERATION |